Transplant Glomerulopathy - Early Form
1 clinical trials · Condition
◉ Watch Transplant Glomerulopathy - Early Form
| Record | Firm | Date |
|---|---|---|
| Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant (NCT03380377) | Stanley Jordan, MD | 2018-02-21 |
Track Transplant Glomerulopathy - Early Form automatically
Every clearance here is in the API, with alerts when new ones post.